MAPT and Alzheimer disease: Therefore, mice with mutations in the gene that encodes tau protein, the MAPT (microtubule-associated protein tau) gene, were developed and produced, sometimes in combination with mutations seen priorly, in an attempt to reach an AD mouse model that can completely mimic the AD clinical condition.